XML 22 R7.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury
Noncontrolling Interests
Beginning balance, common stock (in shares) at Mar. 31, 2023   277          
Beginning balance, treasury common stock (shares) at Mar. 31, 2023           (141)  
Beginning balance at Mar. 31, 2023 $ (1,490) $ 3 $ 7,747 $ 12,295 $ (905) $ (20,997) $ 367
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under employee plans, net of forfeitures (in shares)   1          
Issuance of shares under employee plans, net of forfeitures 17   116     $ (99)  
Share-based compensation 182   182        
Repurchase of common stock (in shares)           (7)  
Repurchase of common stock (3,023)         $ (3,023)  
Net income 3,160     3,002     158
Other comprehensive income (loss) 24       24    
Cash dividends declared (320)     (320)      
Payments to noncontrolling interests (152)           (152)
Other 3   3 1     (1)
Ending balance common stock (in shares) at Mar. 31, 2024   278          
Ending balance, treasury common stock (shares) at Mar. 31, 2024           (148)  
Ending balance at Mar. 31, 2024 (1,599) $ 3 8,048 14,978 (881) $ (24,119) 372
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under employee plans, net of forfeitures (in shares)   1          
Issuance of shares under employee plans, net of forfeitures (47)   101     $ (148)  
Share-based compensation 226   226        
Repurchase of common stock (in shares)           (6)  
Repurchase of common stock (3,172)         $ (3,172)  
Net income 3,481     3,295     186
Other comprehensive income (loss) (51)       (51)    
Cash dividends declared (352)     (352)      
Payments to noncontrolling interests (178)           (178)
Other (2)   (2)       0
Ending balance common stock (in shares) at Mar. 31, 2025   279          
Ending balance, treasury common stock (shares) at Mar. 31, 2025           (154)  
Ending balance at Mar. 31, 2025 (1,694) $ 3 8,373 17,921 (932) $ (27,439) 380
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares under employee plans, net of forfeitures (in shares)   1          
Issuance of shares under employee plans, net of forfeitures (25)   89     $ (114)  
Share-based compensation 247   247        
Repurchase of common stock (in shares)           (6)  
Repurchase of common stock (4,790)   (338)     $ (4,452)  
Net income 5,099           197
Net income 4,959     4,762     197
Other comprehensive income (loss) 187       187    
Cash dividends declared (393)     (393)      
Payments to noncontrolling interests (182)           (182)
Adjustment to fair value of redeemable noncontrolling interests (87)   (87)        
Other 1     1     0
Ending balance common stock (in shares) at Mar. 31, 2026   280          
Ending balance, treasury common stock (shares) at Mar. 31, 2026           (160)  
Ending balance at Mar. 31, 2026 $ (1,777) $ 3 $ 8,284 $ 22,291 $ (745) $ (32,005) $ 395